with respect
This proves you really dont understand science and the clinical trial process, let alone the process to get a implanted device into the marketed
If the trial is designed to include long term follow up it is and patient can be followed up for as long as dictated
Where do you think this company quotes 10 years without calcification from
All the other established valve competitors have published data for 1000s of patients followed up to 10-15 years
So i would not get excited about small number of patients over a small period of time.
It may sound good in a PR Tweet but it really means very little to the big potential partners.
Ann: DurAVR valve patient outcomes exceed expectations, page-47
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.30 |
Change
0.300(1.67%) |
Mkt cap ! $351.7M | |||
| Open | High | Low | Value | Volume |
| $18.25 | $18.30 | $18.01 | $12.33K | 679 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 300 | $18.09 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.30 | 247 | 2 |
View Market Depth
| Last trade - 14.56pm 04/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |